Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care

By J. Leahy. 2008

723 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Pharmacology

View Paper: https://www.semanticscholar.org/paper/a2e902b406baa51058818f2a2f02ceae4d817807

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. V. Basevi
2. Ralph DeFronzo
3. Gerald I. Shulman
4. E. Ferrannini
5. Jens J. Holst
6. Silvio E. Inzucchi
7. I. Hirsch
8. M. S. Kirkman

In Pharmacology

1. Ralph DeFronzo
2. V. Basevi

Citations in the corpus

• Standards of Medical Care in Diabetes—2012 (2011, background): “Regarding drug therapy for diabetes prevention, a consensus panel felt that metformin should be the only drug considered (47).”
• Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis (2016, background): “80 For people with impaired glucose tolerance, lifestyle interventions can reduce the risk of progression to diabetes.”
• Standards of Medical Care in Diabetes—2008 (2008, background): “” Both categories of prediabetes are risk factors for future diabetes and for cardiovascular disease (CVD) (7).”
• Type 2 diabetes mellitus (2015, background): “serves as a consultant for Medtronics and Kamada and is on the speaker’s bureau for Medtronics and Novo Nordisk; (10) F.”